Pacira BioSciences (PCRX) Invested Capital (2010 - 2026)

Pacira BioSciences' Invested Capital history runs 17 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 26.08% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (down 26.08% YoY), while the FY2025 annual figure was $1.1 billion, down 21.88% from the prior year.
• Invested Capital was $1.0 billion for Q1 2026 at Pacira BioSciences, down from $1.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.5 billion in Q4 2022 to a low of $765.2 million in Q2 2022.
• Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2023 and 2026: Invested Capital jumped 59.65% in 2023, then retreated 26.08% in 2026.
• A 5-year view of Invested Capital shows it stood at $1.5 billion in 2022, then fell by 4.91% to $1.4 billion in 2023, then declined by 2.08% to $1.4 billion in 2024, then fell by 21.88% to $1.1 billion in 2025, then fell by 4.11% to $1.0 billion in 2026.
• The last three Invested Capital figures came in at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.